J. W. Faigle

Pharmacokinetics and Metabolism of the Anti-Inflammatory Agent Voltaren

H. Stierlin, P.H. Degen, J. W. Faigle et al. · Scandinavian Journal of Rheumatology · 1978 · 181 citations

Pharmacotherapy, Experimental Pharmacology, Molecular Pharmacology +18

Biotransformation of diclofenac sodium (Voltaren®) in animals and in man

H. Stierlin, J. W. Faigle, A. Sallmann et al. · Xenobiotica · 1979 · 178 citations

The metabolism of¹⁴C-oxcarbazepine in man

Helmut Schütz, K. F. Feldmann, J. W. Faigle et al. · Xenobiotica · 1986 · 149 citations

Molecular Pharmacology, Gp 47,779, Faecal Excretion +15

Biotransformation of Diclofenac Sodium (Voltaren®) in Animals and in Man.: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile

H. Stierlin, J. W. Faigle · Xenobiotica · 1979 · 126 citations

Unchanged Drug, Dog Bile, Laboratory Animal Study +24

The metabolic fate of thalidomide

J. W. Faigle, H. Keberle, Karl Schmid · Cellular and Molecular Life Sciences · 1962 · 111 citations

Metabolic Fate, Energy Metabolism, Biochemistry +6